Finance

Lists
Q3 2026 earnings • in 1 day
See details
OPK:NASDAQ
OPKO Health Inc
1,72 USD
+3,61%
(+0,060) 1D
1,73 USD
+0,58% (+0,0100)
Pre-market
Closed: 2-ноя., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OPK...
Open
1,68 USD
High
1,73 USD
Low
1,68 USD
Mkt. cap
1,28 млд
Avg. vol.
4,34 млн
Volume
53,25 миң
52-wk high
1,77 USD
52-wk low
0,98 USD
EPS
-0,10 USD
Beta
1,51
Shares outstanding
746,33 млн
No. of employees
2 миң
Open
1,68 USD
High
1,73 USD
Low
1,68 USD
Mkt. cap
1,28 млд
Avg. vol.
4,34 млн
Volume
53,25 миң
52-wk high
1,77 USD
52-wk low
0,98 USD
EPS
-0,10 USD
Beta
1,51
Shares outstanding
746,33 млн
No. of employees
2 миң
News stories
From web sources and news partners
About OPKO Health Inc
CEO-
Employees2,28 миң
Founded1991
HeadquartersМайами, Флорида, Америка Кошмо Штаттары
SectorHealth care provider
Websiteopko.com
Analyst ratings
Based on 3 analysts giving stock ratings to OPK in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OPK in the last 3 months.
Highest
Current 1,72 USD
4,00 USD (+132,56%)
Average
3,08 USD (+79,07%)
Lowest
2,25 USD (+30,81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
3,00 USD
+74,4%
10/27/2026
Michael Petusky
Barrington
Buy
Upgraded
2,25 USD
+30,8%
10/16/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
4,00 USD
+132,6%
10/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
3,00 USD
+74,4%
02/27/2026
Next call in 32:18:29
4-ноя., шарш., 23:30
Fiscal period
Q3 2026
- / -0,06 USD
Revenue / Est. (USD)
- / 136,62 млн
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
151,67 млн
148,45 млн
124,20 млн
163,58 млн
Cost of goods sold
131,85 млн
117,20 млн
107,64 млн
116,73 млн
Cost of revenue
131,85 млн
117,20 млн
107,64 млн
116,73 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53,80 млн
55,22 млн
48,61 млн
52,92 млн
Operating expense
73,34 млн
74,27 млн
67,57 млн
71,89 млн
Total operating expenses
205,19 млн
191,47 млн
175,21 млн
188,62 млн
Operating income
-53,52 млн
-43,02 млн
-51,02 млн
-25,04 млн
Other non operating income
610,00 миң
-354,00 миң
139,00 миң
1,63 млн
EBT including unusual items
41,43 млн
-46,92 млн
-60,96 млн
-13,40 млн
EBT excluding unusual items
-60,15 млн
-51,38 млн
-57,31 млн
-31,47 млн
Income tax expense
19,80 млн
-15,66 млн
-6,11 млн
-4,98 млн
Effective tax rate
47,79%
33,38%
10,02%
37,19%
Other operating expenses
-
-
-
-
Net income
21,63 млн
-31,26 млн
-54,85 млн
-8,42 млн
Net profit margin
14,26%
-21,06%
-44,16%
-5,14%
Earnings per share
-
-0,04
-
-0,03
Interest and investment income
3,02 млн
3,82 млн
3,01 млн
3,22 млн
Interest expense
-11,36 млн
-11,31 млн
-10,94 млн
-11,38 млн
Net interest expenses
-8,34 млн
-7,49 млн
-7,93 млн
-8,16 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-30,78 млн
-20,64 млн
-28,82 млн
-2,63 млн
Gain or loss from assets sale
-101,56 млн
601,00 миң
-34,00 миң
-17,92 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору